Cardiovascular magnetic resonance imaging in heart failure

References

• Roth GA, Forouzanfar MH, Moran AE, et al. Demographic and epidemiologic drivers of global cardiovascular mortality.N. Engl J Med. 2015;372:1333–1341.
   PubMed Web of Science ®Google Scholar
• Heidenreich PA, Albert NM, Allen LA, et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circul Heart Fail. 2013;6:606–619.
   PubMed Web of Science ®Google Scholar
• Bursi F, Weston SA, Redfield MM, et al. Systolic and diastolic heart failure in the community. Jama. 2006;296:2209–2216.
   PubMed Web of Science ®Google Scholar
• Sakuma H, Suzawa N, Ichikawa Y, et al. Diagnostic accuracy of stress first-pass contrast-enhanced myocardial perfusion MRI compared with stress myocardial perfusion scintigraphy.AJR. Am J Roentgenol. 2005;185:95–102.
   PubMed Web of Science ®Google Scholar
• Wagner A, Mahrholdt H, Holly TA, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet. 2003;361:374–379.
   PubMed Web of Science ®Google Scholar
• Biglands JD, Radjenovic A, Ridgway JP. Cardiovascular magnetic resonance physics for clinicians: part II. J Cardiovasc Magn Reson. 2012;14:66.
   PubMedGoogle Scholar
• Lam CS, Roger VL, Rodeheffer RJ, et al. Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. J Am Coll Cardiol. 2009;53:1119–1126.
   PubMed Web of Science ®Google Scholar
• Rathi VK, Doyle M, Yamrozik J, et al. Routine evaluation of left ventricular diastolic function by cardiovascular magnetic resonance: a practical approach.J. Cardiovasc Magn Reson. 2008;10:36.
   PubMed Web of Science ®Google Scholar
• Yoneyama K, Suzuki K, Izumo M, et al. Intra-ventricular rebound flow and systolic anterior motion of the mitral valve with left ventricular outflow tract obstruction in elderly, hypertensive women. Int J Cardiol. 2015;189:164–167.
   PubMed Web of Science ®Google Scholar
• Frydrychowicz A, Weigang E, Harloff A, et al. Images in cardiovascular medicine. Time-resolved 3-dimensional magnetic resonance velocity mapping at 3 T reveals drastic changes in flow patterns in a partially thrombosed aortic arch. Circulation. 2006;113:e460–461.
   PubMed Web of Science ®Google Scholar
• Abdel-Aty H, Zagrosek A, Schulz-Menger J, et al. Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation. 2004;109:2411–2416.
   PubMed Web of Science ®Google Scholar
• Aletras AH, Tilak GS, Natanzon A, et al. Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: histopathological and displacement encoding with stimulated echoes (DENSE) functional validations. Circulation. 2006;113:1865–1870.
   PubMed Web of Science ®Google Scholar
• Von Knobelsdorff-Brenkenhoff F, Prothmann M, Dieringer MA, et al. Myocardial T1 and T2 mapping at 3 T: reference values, influencing factors and implications. J Cardiovasc Magn Reson. 2013;15:53.
   PubMed Web of Science ®Google Scholar
• Ambale-Venkatesh B, Lima JA, Cardiac MRI. a central prognostic tool in myocardial fibrosis. Nat Rev Cardiol. 2015;12:18–29.
   PubMed Web of Science ®Google Scholar
• Iles L, Pfluger H, Phrommintikul A, et al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol. 2008;52:1574–1580.
   PubMed Web of Science ®Google Scholar
• Yancy CW, Jessup M, Bozkurt B, et al. ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017;136:e137–e161.
   PubMed Web of Science ®Google Scholar
• Eng J, McClelland RL, Gomes AS, et al. Adverse left ventricular remodeling and age assessed with cardiac MR imaging: the multi-ethnic study of atherosclerosis. Radiology. 2016;273:714-722.
   PubMed Web of Science ®Google Scholar
• Yoneyama K, Gjesdal O, Choi EY, et al. Age, sex, and hypertension-related remodeling influences left ventricular torsion assessed by tagged cardiac magnetic resonance in asymptomatic individuals: the multi-ethnic study of atherosclerosis. Circulation. 2012;126:2481–2490.
   PubMed Web of Science ®Google Scholar
• Rodriguez CJ, Diez-Roux AV, Moran A, et al. Left ventricular mass and ventricular remodeling among hispanic subgroups compared with non-Hispanic blacks and whites: MESA (multi-ethnic study of atherosclerosis). J Am Coll Cardiol. 2010;55:234–242.
   PubMed Web of Science ®Google Scholar
• Yoneyama K, Venkatesh BA, Bluemke DA, et al. Cardiovascular magnetic resonance in an adult human population: serial observations from the multi-ethnic study of atherosclerosis. J Cardiovasc Magn Reson. 2017;19:52.
   PubMed Web of Science ®Google Scholar
• Bluemke DA, Kronmal RA, Lima JA, et al. The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (multi-ethnic study of atherosclerosis) study. J Am Coll Cardiol. 2008;52:2148–2155.
   PubMed Web of Science ®Google Scholar
• Cheng S, Fernandes VR, Bluemke DA, et al. Age-related left ventricular remodeling and associated risk for cardiovascular outcomes: the multi-ethnic study of atherosclerosis. Circ Cardiovasc Imaging. 2009;2:191–198.
   PubMed Web of Science ®Google Scholar
• Rosen BD, Edvardsen T, Lai S, et al. Left ventricular concentric remodeling is associated with decreased global and regional systolic function: the multi-ethnic study of atherosclerosis. Circulation. 2005;112:984–991.
   PubMed Web of Science ®Google Scholar
• Turkbey EB, Backlund JY, Genuth S, et al. Myocardial structure, function, and scar in patients with type 1 diabetes mellitus. Circulation. 2011;124:1737–1746.
   PubMedGoogle Scholar
• Ambale Venkatesh B, Volpe GJ, Donekal S, et al. Association of longitudinal changes in left ventricular structure and function with myocardial fibrosis: the multi-ethnic study of atherosclerosis study. Hypertension. 2014;64:508–515.
   PubMed Web of Science ®Google Scholar
• Shah RV, Murthy VL, Abbasi SA, et al. Weight loss and progressive left ventricular remodelling: the multi-ethnic study of atherosclerosis (MESA). Eur J Prev Cardiol. 2015;22:1408–1418.
   PubMed Web of Science ®Google Scholar
• Yoneyama K, Donekal S, Venkatesh BA, et al. Natural history of myocardial function in an adult human population: serial longitudinal observations from MESA. JACC Cardiovasc Imaging. 2016;9:1164–1173.
   PubMed Web of Science ®Google Scholar
• Turkbey EB, Nacif MS, Guo M, et al. Prevalence and correlates of myocardial scar in a US Cohort. Jama. 2015;314:1945–1954.
   PubMed Web of Science ®Google Scholar
• Schelbert EB, Cao JJ, Sigurdsson S, et al. Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults. Jama. 2012;308:890–896.
   PubMed Web of Science ®Google Scholar
• Kwong RY, Chan AK, Brown KA, et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation. 2006;113:2733–2743.
   PubMed Web of Science ®Google Scholar
• Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445–1453.
   PubMed Web of Science ®Google Scholar
• Omori T, Kurita T, Dohi K, et al. Prognostic impact of unrecognized myocardial scar in the non-culprit territories by cardiac magnetic resonance imaging in patients with acute myocardial infarction. Eur Heart J Cardiovasc Imaging. 2018;19:108–116.
   PubMed Web of Science ®Google Scholar
• Stone GW, Selker HP, Thiele H, et al. Relationship between infarct size and outcomes following primary PCI: patient-level analysis from 10 randomized trials. J Am Coll Cardiol. 2016;67:1674–1683.
   PubMed Web of Science ®Google Scholar
• Nijveldt R, Hofman MB, Hirsch A, et al. Assessment of microvascular obstruction and prediction of short-term remodeling after acute myocardial infarction: cardiac MR imaging study. Radiology. 2009;250:363–370.
   PubMed Web of Science ®Google Scholar
• Wu KC, Zerhouni EA, Judd RM, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation. 1998;97:765–772.
   PubMed Web of Science ®Google Scholar
• De Waha S, Patel MR, Granger CB, et al. Relationship between microvascular obstruction and adverse events following primary primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials. Eur Heart J. 2017;38:3502-3510.
   Google Scholar
• Liu D, Borlotti A, Viliani D, et al. CMR native T1 mapping allows differentiation of reversible versus irreversible myocardial damage in ST-segment-elevation myocardial infarction: an OxAMI Study (Oxford Acute Myocardial Infarction). Circ Cardiovasc Imaging. 2017;10. pii: e005986. doi: 10.1161/CIRCIMAGING.116.005986.
   Web of Science ®Google Scholar
• O’Mahony C, Elliott P, McKenna W. Sudden cardiac death in hypertrophic cardiomyopathy. Circ Arrhythm Electrophysiol. 2013;6:443–451.
   PubMed Web of Science ®Google Scholar
• Maron BJ, Maron MS, Semsarian C. Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives. J Am Coll Cardiol. 2012;60:705–715.
   PubMed Web of Science ®Google Scholar
• Hindieh W, Weissler-Snir A, Hammer H, et al. Discrepant measurements of maximal left ventricular wall thickness between cardiac magnetic resonance imaging and echocardiography in patients with hypertrophic cardiomyopathy. Circ Cardiovasc Imaging. 2017;10. pii: e006309. doi: 10.1161/CIRCIMAGING.117.006309.
   Web of Science ®Google Scholar
• Kwon DH, Smedira NG, Rodriguez ER, et al. Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia. J Am Coll Cardiol. 2009;54:242–249.
   PubMed Web of Science ®Google Scholar
• Rubinshtein R, Glockner JF, Ommen SR, et al. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Circ Heart Fail. 2010;3:51–58.
   PubMed Web of Science ®Google Scholar
• Weng Z, Yao J, Chan RH, et al. Prognostic value of LGE-CMR in HCM: a meta-analysis.JACC. Cardiovasc Imaging. 2016;9:1392–1402.
   PubMed Web of Science ®Google Scholar
• Maron BJ, Ommen SR, Semsarian C, et al. Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine. J Am Coll Cardiol. 2014;64:83–99.
   PubMed Web of Science ®Google Scholar
• Maron BJ. Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy. Circulation. 2010;121:445–456.
   PubMed Web of Science ®Google Scholar
• Valeti US, Nishimura RA, Holmes DR, et al. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2007;49:350–357.
   PubMed Web of Science ®Google Scholar
• Froehlich W, Bogun FM, Crawford TC. Cardiac Sarcoidosis. Circulation. 2015;132:e137–138.
   PubMed Web of Science ®Google Scholar
• Kouranos V, Tzelepis GE, Rapti A, et al. Complementary role of CMR to conventional screening in the diagnosis and prognosis of cardiac sarcoidosis. JACC Cardiovasc Imaging. 2017;10:1437–1447.
   PubMed Web of Science ®Google Scholar
• Austin BA, Tang WH, Rodriguez ER, et al. Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis. JACC Cardiovasc Imaging. 2009;2:1369–1377.
   PubMed Web of Science ®Google Scholar
• Fontana M, Banypersad SM, Treibel TA, et al. Native T1 mapping in transthyretin amyloidosis.JACC. Cardiovasc Imaging. 2014;7:157–165.
   PubMed Web of Science ®Google Scholar
• Banypersad SM, Fontana M, Maestrini V, et al. T1 mapping and survival in systemic light-chain amyloidosis. Eur Heart J. 2015;36:244–251.
   PubMed Web of Science ®Google Scholar
• Karamitsos TD, Piechnik SK, Banypersad SM, et al. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging. 2013;6:488–497.
   PubMed Web of Science ®Google Scholar
• Martinez-Naharro A, Treibel TA, Abdel-Gadir A, et al. Magnetic resonance in transthyretin cardiac amyloidosis. J Am Coll Cardiol. 2017;70:466–477.
   PubMed Web of Science ®Google Scholar
• Kawel N, Nacif M, Arai AE, et al. Trabeculated (noncompacted) and compact myocardium in adults: the multi-ethnic study of atherosclerosis. Circ Cardiovasc Imaging. 2012;5:357–366.
   PubMed Web of Science ®Google Scholar
• Zemrak F, Ahlman MA, Captur G, et al. The relationship of left ventricular trabeculation to ventricular function and structure over a 9.5-year follow-up: the MESA study. J Am Coll Cardiol. 2014;64:1971–1980.
   PubMed Web of Science ®Google Scholar
• Andreini D, Pontone G, Bogaert J, et al. Long-term prognostic value of cardiac magnetic resonance in left ventricle noncompaction: a prospective multicenter study. J Am Coll Cardiol. 2016;68:2166–2181.
   PubMed Web of Science ®Google Scholar
• Wu KC, Weiss RG, Thiemann DR, et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol. 2008;51:2414–2421.
   PubMed Web of Science ®Google Scholar
• Assomull RG, Prasad SK, Lyne J, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol. 2006;48:1977–1985.
   PubMed Web of Science ®Google Scholar
• Bello D, Shah DJ, Farah GM, et al. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation. 2003;108:1945–1953.
   PubMed Web of Science ®Google Scholar
• Daubert C, Behar N, Martins RP, et al. Avoiding non-responders to cardiac resynchronization therapy: a practical guide. Eur Heart J. 2017;38:1463–1472.
   PubMed Web of Science ®Google Scholar
• Wong JA, Yee R, Stirrat J, et al. Influence of pacing site characteristics on response to cardiac resynchronization therapy. Circ Cardiovasc Imaging. 2013;6:542–550.
   PubMed Web of Science ®Google Scholar
• Hoke U, Khidir MJ, Van Der Geest RJ, et al. Relation of myocardial contrast-enhanced T1 mapping by cardiac magnetic resonance to left ventricular reverse remodeling after cardiac resynchronization therapy in Patients with nonischemic cardiomyopathy. Am J Cardiol. 2017;119:1456–1462.
   PubMed Web of Science ®Google Scholar
• Nakamori S, Dohi K, Ishida M, et al. Native T1 mapping and extracellular volume mapping for the assessment of diffuse myocardial fibrosis in dilated cardiomyopathy. JACC Cardiovasc Imaging. 2017;10:48-59.
   PubMed Web of Science ®Google Scholar
• Puntmann VO, Carr-White G, Jabbour A, et al. T1-mapping and outcome in nonischemic cardiomyopathy: all-cause mortality and heart failure. JACC Cardiovasc Imaging. 2016;9:40–50.
   PubMed Web of Science ®Google Scholar
• Kass DA, Bronzwaer JG, Paulus WJ. What mechanisms underlie diastolic dysfunction in heart failure? Circ Res. 2004;94:1533–1542.
   PubMed Web of Science ®Google Scholar
• Conrad CH, Brooks WW, Hayes JA, et al. Myocardial fibrosis and stiffness with hypertrophy and heart failure in the spontaneously hypertensive rat. Circulation. 1995;91:161–170.
   PubMed Web of Science ®Google Scholar
• Ellims AH, Shaw JA, Stub D, et al. Diffuse myocardial fibrosis evaluated by post-contrast t1 mapping correlates with left ventricular stiffness. J Am Coll Cardiol. 2014;63:1112–1118.
   PubMedGoogle Scholar
• Rommel KP, Von Roeder M, Latuscynski K, et al. Extracellular volume fraction for characterization of patients with heart failure and preserved ejection fraction. J Am Coll Cardiol. 2016;67:1815–1825.
   PubMed Web of Science ®Google Scholar
• Mordi IR, Singh S, Rudd A, et al. Comprehensive echocardiographic and cardiac magnetic resonance evaluation differentiates among heart failure with preserved ejection fraction patients, hypertensive patients, and healthy control subjects. JACC Cardiovasc Imaging. 2017.
   Google Scholar
• Schelbert EB, Fridman Y, Wong TC, et al. Temporal relation between myocardial fibrosis and heart failure with preserved ejection fraction: association with baseline disease severity and subsequent outcome. JAMA Cardiol. 2017;2:995–1006.
   PubMed Web of Science ®Google Scholar
• Azevedo CF, Amado LC, Kraitchman DL, et al. Persistent diastolic dysfunction despite complete systolic functional recovery after reperfused acute myocardial infarction demonstrated by tagged magnetic resonance imaging. Eur Heart J. 2004;25:1419–1427.
   PubMed Web of Science ®Google Scholar
• Ambale-Venkatesh B, Armstrong AC, Liu CY, et al. Diastolic function assessed from tagged MRI predicts heart failure and atrial fibrillation over an 8-year follow-up period: the multi-ethnic study of atherosclerosis. Eur Heart J Cardiovasc Imaging. 2014;15:442–449.
   PubMed Web of Science ®Google Scholar
• Edvardsen T, Rosen BD, Pan L, et al. Regional diastolic dysfunction in individuals with left ventricular hypertrophy measured by tagged magnetic resonance imaging–the multi-ethnic study of atherosclerosis (MESA). Am Heart J. 2006;151:109–114.
   PubMed Web of Science ®Google Scholar
• Choi EY, Rosen BD, Fernandes VR, et al. Prognostic value of myocardial circumferential strain for incident heart failure and cardiovascular events in asymptomatic individuals: the multi-ethnic study of atherosclerosis. Eur Heart J. 2013;34:2354–2361.
   PubMed Web of Science ®Google Scholar
• Ohyama Y, Ambale-Venkatesh B, Noda C, et al. Association of aortic stiffness with left ventricular remodeling and reduced left ventricular function measured by magnetic resonance imaging clinical perspective. Circul Cardiovasc Imaging. 2016;9:e004426.
   PubMed Web of Science ®Google Scholar
• Ohyama Y, Teixido-Tura G, Ambale-Venkatesh B, et al. Ten-year longitudinal change in aortic stiffness assessed by cardiac MRI in the second half of the human lifespan: the multi-ethnic study of atherosclerosis. Eur Heart J Cardiovasc Imaging. 2016;17:1044–1453.
   Web of Science ®Google Scholar
• Gerster M, Peker E, Nagel E, et al. Deciphering cardiac involvement in systemic inflammatory diseases: noninvasive tissue characterisation using cardiac magnetic resonance is key to improved patients’ care. Expert Rev Cardiovasc Ther. 2016;14:1283–1295.
   PubMed Web of Science ®Google Scholar
• McCrohon JA, Moon JC, Prasad SK, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation. 2003;108:54–59.
   PubMed Web of Science ®Google Scholar
• Karamitsos TD, Francis JM, Myerson S, et al. The role of cardiovascular magnetic resonance imaging in heart failure. J Am Coll Cardiol. 2009;54:1407–1424.
   PubMed Web of Science ®Google Scholar
• Puntmann VO, Peker E, Chandrashekhar Y, et al. T1 mapping in characterizing myocardial disease: a comprehensive review. Circ Res. 2016;119:277–299.
   PubMed Web of Science ®Google Scholar
• Montant P, Sigovan M, Revel D, et al. MR imaging assessment of myocardial edema with T2 mapping. Diagn Interv Imaging. 2015;96:885–890.
   PubMed Web of Science ®Google Scholar
• Wassmuth R, Prothmann M, Utz W, et al. Variability and homogeneity of cardiovascular magnetic resonance myocardial T2-mapping in volunteers compared to patients with edema. J Cardiovasc Magn Reson. 2013;15:27.
   PubMed Web of Science ®Google Scholar
• Park CH, Choi EY, Kwon HM, et al. Quantitative T2 mapping for detecting myocardial edema after reperfusion of myocardial infarction: validation and comparison with T2-weighted images. Int J Cardiovasc Imaging. 2013;29(Suppl 1):65–72.
   PubMedGoogle Scholar
• Nishii T, Kono AK, Shigeru M, et al. Cardiovascular magnetic resonance T2 mapping can detect myocardial edema in idiopathic dilated cardiomyopathy. Int J Cardiovasc Imaging. 2014;30(Suppl 1):65–72.
   PubMedGoogle Scholar
• Mayr A, Klug G, Feistritzer HJ, et al. Myocardial edema in acute myocarditis: relationship of T2 relaxometry and late enhancement burden by using dual-contrast turbo spin-echo MRI. Int J Cardiovasc Imaging. 2017;33:1789–1794.
   PubMed Web of Science ®Google Scholar
• Fernandez-Jimenez R, Galan-Arriola C, Sanchez-Gonzalez J, et al. Effect of ischemia duration and protective interventions on the temporal dynamics of tissue composition after myocardial infarction. Circ Res. 2017;121:439–450.
   PubMed Web of Science ®Google Scholar
• Tahir E, Sinn M, Bohnen S, et al. Acute versus Chronic Myocardial Infarction: diagnostic Accuracy of Quantitative Native T1 and T2 Mapping versus Assessment of Edema on Standard T2-weighted Cardiovascular MR Images for Differentiation. Radiology. 2017;285:83–91.
   PubMed Web of Science ®Google Scholar
• Peterzan MA, Rider OJ, Anderson LJ. The role of cardiovascular magnetic resonance imaging in heart failure. Card Fail Rev. 2016;2:115–122.
   Google Scholar
• Ferreira VM, Piechnik SK, Dall’Armellina E, et al. Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents.J. Cardiovasc Magn Reson. 2014;16:36.
   PubMed Web of Science ®Google Scholar
• Hinojar R, Foote L, Sangle S, et al. Native T1 and T2 mapping by CMR in lupus myocarditis: disease recognition and response to treatment. Int J Cardiol. 2016;222:717–726.
   PubMed Web of Science ®Google Scholar
• Von Roeder M, Rommel KP, Kowallick JT, et al. Influence of left atrial function on exercise capacity and left ventricular function in patients with heart failure and preserved ejection fraction. Circ Cardiovasc Imaging. 2017;10. pii: e006785. doi: 10.1161/CIRCIMAGING.117.006785.
   Google Scholar
• Kowallick JT, Kutty S, Edelmann F, et al. Quantification of left atrial strain and strain rate using cardiovascular magnetic resonance myocardial feature tracking: a feasibility study. J Cardiovasc Magn Reson. 2014;16:60.
   PubMed Web of Science ®Google Scholar
• Moon JC, Messroghli DR, Kellman P, et al. Myocardial T1 mapping and extracellular volume quantification: a society for cardiovascular magnetic resonance (SCMR) and CMR working group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson. 2013;15:92.
   PubMed Web of Science ®Google Scholar
• Russo RJ, Lampert R, Birgersdotter-Gree U. Risks of MRI in patients with a pacemaker or defibrillator. N Engl J Med. 2017;376:2495–2496.
   PubMed Web of Science ®Google Scholar
• Nazarian S, Hansford R, Rahsepar AA, et al. Safety of magnetic resonance imaging in patients with cardiac devices. N Engl J Med. 2017;377:2555–2564.
   PubMed Web of Science ®Google Scholar